Lucid Diagnostics Unveils Key Unfiled Financial Snapshot
PremiumCompany AnnouncementsLucid Diagnostics Unveils Key Unfiled Financial Snapshot
1M ago
Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results
Premium
Press Releases
Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results
1M ago
Lucid Diagnostics reports Q2 EPS (20c), consensus (22c)
Premium
The Fly
Lucid Diagnostics reports Q2 EPS (20c), consensus (22c)
1M ago
Lucid Diagnostics Insights: Performance and Outlook Update
PremiumCompany AnnouncementsLucid Diagnostics Insights: Performance and Outlook Update
4M ago
PAVmed Provides Business Update and First Quarter 2024 Financial Results
Premium
Press Releases
PAVmed Provides Business Update and First Quarter 2024 Financial Results
4M ago
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
Premium
Press Releases
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
4M ago
Lucid Diagnostics price target lowered to $3 from $3.80 at Cantor Fitzgerald
PremiumThe FlyLucid Diagnostics price target lowered to $3 from $3.80 at Cantor Fitzgerald
6M ago
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
Premium
Press Releases
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
6M ago
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results
Premium
Press Releases
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100